Most trusted source for Tendering Opportunities and Business Intelligence since 2002
Country - Germany
Summary - Conclusion Of A Non-Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Code Book V For The Active Ingredient Aripiprazole (Excl. Dafo For The Production Of A Dis), (Obo) Atc N05Ax12 For The Period 01.02.2025 - 31.01.2027
Deadline - Dec 04, 2026
GT reference number - 99881581
Product classification - Pharmaceutical products
Address - Germany
Contact details - 565656565
Tender notice no. - 76454545
GT Ref Id - 99881581
Document Type - Tender Notices
Description - Description: Section 130a paragraph 8 SGB V enables health insurance companies and pharmaceutical companies to conclude framework discount agreements for medicines dispensed at the expense of statutory health insurance companies. In view of the relev ant statutory provisions for the award of public contracts, DAK-Gesundheit carries out a regular process of active ingredient-related, formal award procedures in accordance with the provisions of Part 4 of the GWB. For medicines containing the above-mentioned active ingredient, aripiprazole (only dosage forms for the manufacture of a depot injection suspension), ATC N05AX12, which are to be specified by the bidder in Annex 2 to the contract, DAK-
Gt Ref Id - 99881581
Deadline - Dec 04, 2026
Similar Tenders :
Why Us
3,00,000 +
Users
190 +
Countries Covered
5,00,000 +
Agencies Tracked
50,000 +
Notices Daily
90 Million +
Database